golf ... like the optimism, thinking the same way. Patience is a virtue I am told, but it is "grinding" in this case. Hopefully, we get the jump start on pps if/when a credible well known BP partner is identified. This should reduce some stock risk concerns, and probably paint the path forward much more clearly - any BP offering significant operating cash, BoM2 study financing, and guidance/oversight will not be doing so for a boy scout merit badge or to better position for St Peter. Whether explicitly stated & documented or not, it will represent a C-L-E-A-R endorsement and belief in apabetalone, the future of epigenetics, and a strong desire to take on RVX in the future. A partnering deal in line with what we are discussing/expecting/hoping will realistically be the preliminary stage of a tiered and segmented purchase plan with some early positioning, and cost (in return for additional proof of concept and de-risking). This has GOT TO BE worth something, in the interim pps, or I am a monkey's uncle (but those two are not mutually exclusive though!).

All sounds good right? Just need to see it actually happen now.

glta